News|Videos|June 19, 2024
Clinical Advice on Caring for Patients Treated With Talquetamab
The panel provides clinical advice on caring for patients with multiple myeloma who are treated with talquetamab.
Advertisement
Episodes in this series
Advertisement
Related to this article
European survey reveals how oncology nurses manage complex multiple myeloma care amid time and resource constraints.
Nicole Doell, MSN, RN, of Sylvester explains how nurses can address breast cancer misinformation without judgment and share vetted resources.
A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.
Oral vitamin C did not slow clonal growth in the phase 2 EVITA trial but was linked to longer survival.
Sylvester's Nicole Doell, MSN, RN, discusses how oncology nurses can support patients with breast cancer emotionally, from diagnosis to survivorship.
Kathryn Shady, PhD, RN, OCN, discusses research on emotional dissonance and vicarious trauma among hematology/oncology nurses.
Daraxonrasib, tarlatamab, an mRNA melanoma therapy and ivonescimab led ESMO 2026. Tell us which findings you can act on now.
At an Oncology Nursing News roundtable, APPs discussed earlier lifileucel referral, IL-2 dosing, and toxicities that emerge after discharge.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
October 2026 FDA Approvals: 7 Cancer Updates for Oncology Nurses
2
What Nurses Should Tell Patients About Vitamin C in CCUS and MDS
3
Vicarious Trauma Affects Oncology Nurses in Every Care Setting
4
How Oncology Nurses Can Overcome Common Barriers to Research
5